Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1997 1
1998 4
1999 5
2000 3
2001 2
2002 4
2003 4
2004 4
2005 2
2006 7
2007 13
2008 15
2009 18
2010 16
2011 24
2012 29
2013 39
2014 34
2015 64
2016 52
2017 43
2018 72
2019 65
2020 78
2021 116
2022 124
2023 96
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

859 results

Results by year

Filters applied: . Clear all
Page 1
Retraction Statement.
[No authors listed] [No authors listed] Int J Clin Pract. 2021 Dec;75(12):e14927. doi: 10.1111/ijcp.14927. Epub 2021 Oct 12. Int J Clin Pract. 2021. PMID: 34636466
Retraction Statement: Ali, M, Imran, M M, Ahmad, U, Usman, U, Shaukat, A, Gul, N Neutrophil/lymphocyte ratio-A marker of COVID-19 pneumonia severity. ...The retraction has been agreed following a disclosure by the authors that the data in their article was not original and …
Retraction Statement: Ali, M, Imran, M M, Ahmad, U, Usman, U, Shaukat, A, Gul, N Neutrophil/lymphocyte ratio-A marker of COVID-19 pne …
Retraction Statement.
[No authors listed] [No authors listed] Int J Clin Pract. 2021 Dec;75(12):e14926. doi: 10.1111/ijcp.14926. Epub 2021 Oct 12. Int J Clin Pract. 2021. PMID: 34636459 Free PMC article.
Retraction Statement: Ali, M, Imran, M M, Ahmad, U, Usman, U, Shaukat, A, Gul, N Clinical characteristics and outcomes of patients with COVID-19 pneumonia admitted to an intensive care unit in Faisalabad, Pakistan. ...The retraction has been agreed following a disclosure b …
Retraction Statement: Ali, M, Imran, M M, Ahmad, U, Usman, U, Shaukat, A, Gul, N Clinical characteristics and outcomes of patients wi …
CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review.
Chan LY, Dass SA, Tye GJ, Imran SAM, Wan Kamarul Zaman WS, Nordin F. Chan LY, et al. Biomedicines. 2022 Mar 30;10(4):804. doi: 10.3390/biomedicines10040804. Biomedicines. 2022. PMID: 35453554 Free PMC article. Review.
This novel therapeutic discovery combines fragments of monoclonal antibodies with the signalling and co-stimulatory domains that have been modified to its current fourth generation. CAR has been widely implemented in T-cells and natural killer (NK) cells immunotherapy. The …
This novel therapeutic discovery combines fragments of monoclonal antibodies with the signalling and co-stimulatory domains that have been m …
Ibn Imran's 10th century Treatise on Melancholy.
Omrani A, Holtzman NS, Akiskal HS, Ghaemi SN. Omrani A, et al. J Affect Disord. 2012 Dec 10;141(2-3):116-9. doi: 10.1016/j.jad.2012.02.004. Epub 2012 Mar 3. J Affect Disord. 2012. PMID: 22386476
In contrast to these assumptions, here we describe one of the earliest texts on melancholia and mania, by Ibn Imran, an Arab physician of the 10th century....
In contrast to these assumptions, here we describe one of the earliest texts on melancholia and mania, by Ibn Imran, an Arab physicia …
Nanomedicine for glioblastoma: Progress and future prospects.
Khan I, Baig MH, Mahfooz S, Imran MA, Khan MI, Dong JJ, Cho JY, Hatiboglu MA. Khan I, et al. Semin Cancer Biol. 2022 Nov;86(Pt 2):172-186. doi: 10.1016/j.semcancer.2022.06.007. Epub 2022 Jun 26. Semin Cancer Biol. 2022. PMID: 35760272 Review.
Clinical pharmacokinetics of nadolol: A systematic review.
Kalsoom S, Zamir A, Rehman AU, Ashraf W, Imran I, Saeed H, Majeed A, Alqahtani F, Rasool MF. Kalsoom S, et al. J Clin Pharm Ther. 2022 Oct;47(10):1506-1516. doi: 10.1111/jcpt.13764. Epub 2022 Aug 30. J Clin Pharm Ther. 2022. PMID: 36040016 Review.
RESULTS AND DISCUSSION: The area under the plasma concentration curve (AUC) and maximum plasma concentration (C(max) ) of nadolol increased in a dose-dependent manner. The t of nadolol was increased to double (18.2-68.6 h) in the patients with chronic kidney disease while …
RESULTS AND DISCUSSION: The area under the plasma concentration curve (AUC) and maximum plasma concentration (C(max) ) of nadolol increased …
Clinical pharmacokinetics of nebivolol: a systematic review.
Hanif N, Zamir A, Imran I, Saeed H, Majeed A, Rehman AU, Ashraf W, Alqahtani F, Rasool MF. Hanif N, et al. Drug Metab Rev. 2023 Nov;55(4):428-440. doi: 10.1080/03602532.2023.2271195. Epub 2023 Oct 28. Drug Metab Rev. 2023. PMID: 37849071 Review.
The clearance (CL) was increased in obese than in controls from 51.6 11.6 L/h to 71.6 17.4 L/h when 0.5 mg/ml IV solution was infused. Nebivolol showed higher C(max), AUC(0-) and half-life (t(1/2)) when co-administered with bupropion, duloxetine, fluvoxamine, paroxetine, l …
The clearance (CL) was increased in obese than in controls from 51.6 11.6 L/h to 71.6 17.4 L/h when 0.5 mg/ml IV solution was infused. Nebiv …
859 results